Latest News Archive

Please select Category, Year, and then Month to display items

Monique Tangah – this year’s winner of UFS ‘3MT’

21 October 2020 | Story Andre Damons | Photo Supplied

Monique Tangah_web read more — Monique Tangah (Economic and Management Sciences Faculty) won the PhD category of UFS Institutional Three-Minute Thesis competition hosted by the Postgraduate School.

Monique Tangah, a postgraduate student from the Faculty of Economic and Management Sciences at the University of the Free State (UFS), will represent the university on 13 November 2020 at the National Three-Minute Thesis, also known as the ‘3MT’, competition after she won the UFS competition.

The UFS Postgraduate School hosted its Institutional 3MT on 9 October 2020 and winners chosen from each faculty competed against each other for the UFS Three-Minute Thesis title. Tangah, with her thesis titled, Cameroonian women’s empowerment through higher education: An African-feminist and Capability Approach Analysis, emerged victorious from a total of 20 students who are registered for their PhD and master's degrees. Tensions were high as the participants brought their research products of a very high standard forward in the virtual competition.

Willard Morgan, a student in the Faculty of Education, won the category for the Master’s Degree students with his title, Ideological representations of entrepreneurship in high school economic and management sciences textbooks.

The Three-Minute Thesis competition is an annual competition held at 200 universities across the world. It is open to PhD and master's students and challenges participants to present their research in just 180 seconds – in a way that is understood by an audience with no background in their specific research area.

Universities need to focus on the generation of new knowledge to solve critical problems in the country, continent and globally. The Three-Minute Thesis competition aims to achieve this by encouraging the increase of research output produced by master’s and PhD students.

Winners and runners-up of the UFS competition for 2020 are:

For the PhD category

Winner: Monique Tangah (Economic and Management Sciences Faculty)

1st runner-up: Tamson Foster (Natural and Agricultural Sciences Faculty)

2nd runner-up: Monique Basson (Humanities)

For the Master’s category

Winner: Willard Morgan (Education)

1st runner-up: Kyla Dooley (Natural and Agricultural Sciences Faculty)

2nd runner-up: Bonolo Makhalemele (Natural and Agricultural Sciences Faculty)

The National Three-Minute thesis will be hosted virtually on 13 November 2020. PhD finalists from South African universities will compete for the 3MT SA title. Whose research thesis will stand the test of time? Join to find out.

Date: 13 November 2020

Time: 10:00-13:00

Link: https://eu.bbcollab.com/guest/405aa3ff84f54eec81557131b6bc2bfd

For more information, email Reabetswe Mabine at mabiner@ufs.ac.za

Willard Morgan (Education) was the winner of Master's category of this year’s UFS Institutional Three-Minute Thesis competition hosted by the Postgraduate School.

Bonolo Makhalemele (Natural and Agricultural Sciences Faculty) was the second runner-up

Monique Basson (Humanities) was the second runner-up in the PhD category.

Tamson Foster (Natural and Agricultural Sciences Faculty) was the first runner-up.

Kyla Dooley (Natural and Agricultural Sciences Faculty) was the first runner-up.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept